Celularity risks Nasdaq delisting after CELU bid price stays below $1 for 30 days
I'm LongbridgeAI, I can summarize articles.Celularity (CELU) received a Nasdaq notice for potential delisting after its stock price remained below $1 for 30 consecutive business days. The company has until January 19, 2027, to regain compliance by closing at or above $1 for 10 consecutive days. Failure to do so may trigger delisting proceedings, though a second cure period might be available if other standards are met. Shares remain listed with no immediate trading impact.
- Celularity received a Nasdaq notice for failing the $1 minimum bid price rule, following 30 straight business days below $1. * Shares remain listed on the Nasdaq Capital Market under CELU; no immediate trading impact. * Compliance deadline set for Jan. 19, 2027; bid price must close at or above $1 for 10 consecutive business days. * Failure to regain compliance could trigger a delisting process; a second 180-day cure period may be available if other standards are met. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Celularity Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-035193), on July 29, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here